Login / Signup

Moderate fixed-dose hydroxyurea for primary prevention of strokes in Nigerian children with sickle cell disease: Final results of the SPIN trial.

Najibah A GaladanciShehu U AbdullahiShehi Ali AbubakarBinta Wudil JibirHauwa AminuAliyu TijjaniMuhammad S AbbaMusa A TabariAisha GaladanciAwwal Musa BorodoRaymond BelonwuAuwal S SalihuMark RodeghierDjamila L GhafuriBrittany V Covert C GreeneKathleen NevilleAdetola A KassimFenella Jane KirkhamLori C JordanMuktar H AliyuMichael Rutledge DeBaun
Published in: American journal of hematology (2020)
Keyphrases
  • young adults
  • study protocol
  • phase iii
  • clinical trial
  • phase ii
  • high intensity
  • room temperature
  • density functional theory
  • sickle cell disease
  • single molecule
  • randomized controlled trial
  • open label